Boldenone Undecylenate 200 - Livewell Pharmaceuticals

The history of boldenone undecylenate begins with Ciba’s 1949 patent of the boldenone molecule. By the late 1960s, a version called Parenabol was launched for human use, though its medical application proved short-lived. Its veterinary resurgence came through Squibb’s Equipoise, which targeted lean mass gain in horses. Its slow-releasing undecylenate ester gave it sustained anabolic action with minimal estrogenic activity, traits that later drew attention from non-medical users aiming for long-term muscular enhancement.

Disclaimer: Information provided it this page is for general information only and does not substitute for professional medical advice.

For detailed information about Boldenone Undecylenate 200 by Livewell Pharmaceuticals, consult with your doctor or healthcare professional.